Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,668
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
for
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Durham NC, Charleston SC, St Louis MO, Houston TX
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT05793151
Recruiting
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
for
Mild Cognitive Impairment (MCI), Cognitive Training
Location: Durham NC, New York NY, Miami FL, Seattle WA
Sponsor: Columbia University
Sex: All
Age: 55 - 70+
Code: NCT06601933
Phase 2, Recruiting
A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention
for
Acute Kidney Injury
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 1 - 18
Code: NCT04403633
Recruiting
Follow-up Visit of High Risk Infants
for
Infant, Newborn, Infant, Low Birth Weight,
Location: Durham NC, Philadelphia PA, Atlanta GA, Cincinnati OH,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 1 - 2
Code: NCT00009633
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
for
Solid Tumors
Location: Durham NC, Fairfax VA, New York NY, The Bronx NY,
Sponsor: Quanta Therapeutics
Sex: All
Age: 18+
Code: NCT06227377
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Location: Durham NC, Charlottesville VA, Pittsburgh PA,
Sponsor: Edwards Lifesciences
Sex: All
Age: 0+
Code: NCT02744677
Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
for
Heart Failure With Preserved Ejection Fraction (HFpEF
Location: Durham NC, Charleston SC, Columbus OH, New York NY,
Sponsor: Axon Therapies, Inc.
Sex: All
Age: 40+
Code: NCT04592445
Recruiting
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
for
Cancer Weight Loss
Location: Durham NC, Charlottesville VA, Atlanta GA, New York NY,
Sponsor: Endevica Bio
Sex: All
Age: 18+
Code: NCT06937177
Phase 2, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Durham NC, Chapel Hill NC, Winston-Salem NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase 3, Recruiting
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
for
Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis,
Location: Durham NC, Chapel Hill NC, Boston MA, Milwaukee WI,
Sponsor: UCB Biopharma SRL
Sex: Female
Age: 18+
Code: NCT06888193
Phase 1, Recruiting
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
for
Metastatic Uveal Melanoma, Cutaneous Melanoma,
Location: Durham NC, Philadelphia PA, Cincinnati OH, Nashville TN,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT03947385
Phase 1, Phase 2, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Durham NC, Baltimore MD, Pittsburgh PA, Atlanta GA,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase 3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Durham NC, Chapel Hill NC, Winston-Salem NC,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Durham NC, Chapel Hill NC, Winston-Salem NC,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Durham NC, Chapel Hill NC, Raleigh NC, Cary NC,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Imaging Retinal Vasculature in Infant Eyes
for
Retinopathy of Prematurity
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 0
Code: NCT05558059
Recruiting
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Durham NC, Winston-Salem NC, Concord NC, Charlotte NC,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05633615
Phase 2, Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)